Nephrocare Health Serv L share price
NEPHROPLUS on NSE · data as of 16 Oct 2026
Nephrocare Health Serv L closed at ₹614.35 on 16 Oct 2026 (+0.44% on the day). It is 21.4% below its 52-week high of ₹781.50 (11 Sept 2026) and 37.8% above its 52-week low of ₹446.00 (19 Dec 2025). It is above its 200-day average but below its 50-day average (a pullback within a longer uptrend), with RSI 13 (oversold zone).
Where the price sits
Last 12 months
Weekly closing prices, adjusted for splits and bonus issues.
Returns vs Nifty 50
| Period | NEPHROPLUS | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | −0.3% | +2.8% | −3.1 pts |
| 1 month | −16.4% | −0.3% | −16.1 pts |
| 3 months | −3.4% | −4.9% | +1.5 pts |
| 6 months | +8.3% | −4.3% | +12.6 pts |
Trend and activity
- 50-day average: ₹688.23 (price below)
- 200-day average: ₹611.44 (price above)
- RSI (14 days): 13
- Turnover on 16 Oct 2026: ₹8.3 cr (0.2x the 20-day average volume)
New to these terms? See 52-week high, moving average and RSI.
Quick answers
What is the 52-week high of Nephrocare Health Serv L?
The 52-week high of Nephrocare Health Serv L (NEPHROPLUS) is ₹781.50, reached on 11 Sept 2026. The 52-week low is ₹446.00, on 19 Dec 2025 (NSE, as of 16 Oct 2026).
How has Nephrocare Health Serv L performed in the last year?
A full year of price history is not available yet.
Is Nephrocare Health Serv L in an uptrend?
As of 16 Oct 2026, Nephrocare Health Serv L is above its 200-day average but below its 50-day average (a pullback within a longer uptrend), with RSI 13 (oversold zone). Trend describes the past, not what happens next.
Price facts only, refreshed every trading day. Not a recommendation to buy or sell. Education only. Not investment advice. All stocks · Today's stock lists